.png)
By Hannah Bachmeier, 2026
---
The full potential of advanced peptide drug design relies heavily on the accessibility of high-quality noncanonical amino acids (ncAAs). However, as global demand for these specialized building blocks accelerates, the environmental toll of traditional, fossil-fueled chemical manufacturing threatens to compromise the industry’s sustainability goals.
Biocatalysis bridges this gap by replacing resource-heavy chemical paths with a streamlined, single-step enzymatic synthesis. By operating at ambient pressure and using water as a primary solvent, this green alternative minimizes greenhouse gas emissions and waste by 99%, ensuring the future of medicine is as sustainable as it is effective.
---
Read the full whitepaper to explore the integration of green chemistry principles into peptide manufacturing—and how Aralez Bio is optimizing process mass intensity (PMI) to build a cleaner future for drug discovery.
Download the full whitepaper: Biocatalysis as a Green Alternative to Amino Acid Synthesis (PDF).
.png)
.png)
.png)